ONCOLOGY

Molecular Mechanisms of Prostate Cancer Progression After Castration

Mar 13, 2017 by in ONCOLOGY Comments Off on Molecular Mechanisms of Prostate Cancer Progression After Castration

Phenotype Molecular basis Mechanism Consequence AR-addicted Adrenal or intra-tumoral androgen biosynthesis Androgens produced sufficient to activate AR Responds to androgen biosynthesis inhibitors and selected AR antagonists AR mutation Alters ligand…

read more

Bone-Targeted Therapy: Rationale and Current Status

Mar 13, 2017 by in ONCOLOGY Comments Off on Bone-Targeted Therapy: Rationale and Current Status

Fig. 10.1 The vicious cycle of bone metastases Transforming growth factor beta (TGFβ) is released from resorbed bone matrix and has been shown to augment signaling through parathyroid hormone-related protein…

read more

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer

Mar 13, 2017 by in ONCOLOGY Comments Off on Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer

Target Agent(s) Phase Summary Identifier mTOR Everolimus (Docetaxel) (Bevacizumab) Ib/II Dose-finding/efficacy study; Docetaxel + everolimus + bevacizumab in metastatic CRPC NCT00574769 mTOR Temsirolimus (Bevacizumab) I/II Dose-finding/efficacy study; Temsirolimus + bevacizumab in metastatic CRPC NCT01083368 mTOR Everolimus…

read more

Genetic Counseling

Mar 13, 2017 by in ONCOLOGY Comments Off on Genetic Counseling

Question 7.1 The family depicted has Lynch syndrome (previously referred to as the hereditary nonpolyposis colon cancer [HNPCC]) syndrome. This syndrome is characterized by a high risk to develop colon…

read more

Oncologic Emergencies

Mar 13, 2017 by in ONCOLOGY Comments Off on Oncologic Emergencies

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 34 Oncologic Emergencies Preet Paul Singh QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered answer…

read more

Stem Cell Transplantation

Mar 13, 2017 by in ONCOLOGY Comments Off on Stem Cell Transplantation

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 33 Stem Cell Transplantation Brian Hess and Rizwan Romee QUESTIONS Each of the numbered items below is followed by lettered answers. Select the…

read more

Plasma Cell Neoplasms

Mar 13, 2017 by in ONCOLOGY Comments Off on Plasma Cell Neoplasms

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 31 Plasma Cell Neoplasms Ravi Vij and Jesse Keller QUESTIONS Each of the numbered items below is followed by lettered answers. Select the…

read more

Immunosuppression-Related Malignancies

Mar 13, 2017 by in ONCOLOGY Comments Off on Immunosuppression-Related Malignancies

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> 32 Immunosuppression-Related Malignancies Lee Ratner QUESTIONS Each of the numbered items below is followed by lettered answers. Select the ONE lettered answer that…

read more

Chronic Leukemias

Mar 13, 2017 by in ONCOLOGY Comments Off on Chronic Leukemias

One of the most prognostically significant landmarks is achieving CCyR at 12 months and many other parameters are based on the likelihood of obtaining this response. For example, for patients…

read more
Get Clinical Tree app for offline access